HLA-DRB genotypes in Japanese patients with renal cell carcinoma

Oncology. 2000 Jun;59(1):57-62. doi: 10.1159/000012138.

Abstract

Objectives: Several clinical features, such as the spontaneous regression of some renal cell carcinoma (RCC) metastases after nephrectomy, suggest immune involvement in tumor destruction.

Patients and methods: We investigated the role of genetic variation at the HLA class II loci in RCC by analyzing the HLA-DR antigen and HLA-DRB1, DRB3, DRB4 and DRB5 alleles in 55 patients using the polymerase chain rection.

Results: No statistically significant differences were observed in the frequency of the HLA-DR antigen or HLA-DRB3, DRB4, or DRB5 genes between the patients and a healthy control group. On the other hand, the HLA-DRB1*0403 and *1202 alleles were significantly more frequent in the patients than in the controls (p < 0.001 and p < 0.01, respectively).

Conclusion: RCC might be linked to these two alleles in Japanese patients.

MeSH terms

  • Adult
  • Aged
  • Alleles
  • Carcinoma, Renal Cell / genetics*
  • Female
  • HLA-DR Antigens / genetics*
  • Humans
  • Immunophenotyping
  • Japan
  • Kidney Neoplasms / genetics*
  • Male
  • Middle Aged
  • Polymerase Chain Reaction

Substances

  • HLA-DR Antigens